• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

National Institutes of Health (NIH) - Articles and news items

Antibiotics: resist the resistance

Blog, Z Homepage promo / 15 September 2016 / Niamh Louise Marriott, Digital Content Producer

European Pharmaceutical Review caught up with Destiny Pharma’s CEO, Dr Love, for an exclusive interview to discuss why the pharmaceutical industry needs to radically change its approach to antibiotics in order to combat the threat of bacterial resistance…

Biomarker breakthrough could improve Parkinson’s treatment

Industry news / 16 August 2016 / University of Florida

Scientists have found that using magnetic resonance imaging reveals areas where Parkinson’s disease causes progressive decline in brain activity, a biomarker discovery which will help to evaluate new experimental treatments to slow or stop the disease’s progression…

Diabetes drug pioglitazone may prevent recurring strokes

Industry news / 18 February 2016 / Victoria White

A new study has found that pioglitazone may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes…

Wanted: Zika virus researchers

Blog / 10 February 2016 / Victoria White, European Pharmaceutical Review

The MRC has launched a £1m rapid response funding initiative to better understand the nature of the risk posed by the Zika virus. Find out about this initiative and NIH’s call for research here…

Tenofovir linked to lower bone mineral content in newborns

Industry news / 30 September 2015 / Victoria White

Pregnant women who received the anti-HIV drug in their third trimester gave birth to babies whose bone mineral content was 12% lower than that of infants who were not exposed to the drug…

Study raises doubt about health benefits of omega-3

Industry news / 25 August 2015 / Victoria White

A large clinical trial by researchers at the National Institutes of Health has found that omega-3 supplements did not slow cognitive decline in older people…

Vaccine for West Nile virus enters human clinical trials

Industry news / 7 July 2015 / Victoria White

A new investigational vaccine designed to protect against West Nile Virus infection is being tested in a Phase 1 clinical trial…